• No#766, Tongcheng Road
    Kunshan, Jiangsu Province,China

  • 86-21-2024 2659

  • Get A Quote

        Search:        

Building Block banner
L-Isoleucinamide, N-[(phenylmethoxy)carbonyl]-L-valyl-L-α-glutamyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-, methyl ester
Chemical Name: L-Isoleucinamide, N-[(phenylmethoxy)carbonyl]-L-valyl-L-α-glutamyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-, methyl ester Catalog: 180507753
CAS Number: 210344-96-0 Purity: 96.0% min
Package: 5g,10g,25g,100g,500g,1kg Price: POA
Lead Time: 2-4 weeks

Contact information

We sincerely hope that our Building Blocks can effectively streamline your R&D processes and significantly accelerate the pace of your research and development. Should you have more compounds that need to be custom made, please fell free to contact me via inquiry@pharmacore.cn

Recommended products

  • L-Canavanine sulfate

    190914792

    L-Canavanine sulfate

  • ethyl 2-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetate

    190910755

    ethyl 2-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetate

  • 1-(2-bromoethoxy)-2-[2-(2-bromoethoxy)ethoxy]ethane

    190927617

    1-(2-bromoethoxy)-2-[2-(2-bromoethoxy)ethoxy]ethane

  • 1-Phenylethane-1-thiol

    190918452

    1-Phenylethane-1-thiol

  • 4-[(2Z)-2-[(2E,4E)-5-[1-(5-carboxypentyl)-3,3-dimethylindol-1-ium-2-yl]penta-2,4-dienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate

    190927669

    4-[(2Z)-2-[(2E,4E)-5-[1-(5-carboxypentyl)-3,3-dimethylindol-1-ium-2-yl]penta-2,4-dienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate

  • 4-[(2Z)-2-[(E)-3-[1-(5-carboxypentyl)-3,3-dimethylindol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate

    190918508

    4-[(2Z)-2-[(E)-3-[1-(5-carboxypentyl)-3,3-dimethylindol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate

Copyright @ PHARMACORE CO.,LIMITED. Our products are listed related to patents, for research purposes only, no commercial sales.

Back to the top